ENDRA Life Sciences Inc. – NASDAQ:NDRA

Add to watchlist

$4.55

-1.75

-27.78%

Market closed

Open in 3 days

+6792.78%

month

+6792.78%

quarter

+218.18%

year

Market Cap	2.87M
Enterprise value	N/A

P/E	-0.56
EV/Sales	N/A
EV/EBITDA	0.33
Price/Sales	N/A
Price/Book	N/A
PEG ratio	-0.03
EPS	-1.23

Revenue	N/A
EBITDA	-10.10M
Income	-9.89M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Profit margin
Jun 2023	0	-2.55M
Sep 2023	0	-3.10M
Dec 2023	428.40K	-1.45M	-340.69%
Mar 2024	0	-2.77M

ENDRA Life Sciences Financials Estimate

Q Y

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Analyst Estimates
Dec 2023	428.40K	-1.45M	-340.69%
Mar 2024	0	-2.77M
Oct 2025	100K	-432.18K	-432.19%
Dec 2025	500K	-432.18K	-86.44%

Analysts Price target
Financials & Ratios estimates

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Payout ratio
Payout ratio	0%

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Dividend Yield
2019	0.02%
2020	0%
2021	0%
2022
2023

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Debt to assets
Jun 2023	9244776	2.31M	25.03%
Sep 2023	7602917	2.40M	31.65%
Dec 2023	6754146	1.09M	16.21%
Mar 2024	5060701	1.36M	26.92%

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Cash Flow
Jun 2023	-2.26M	0	4.73M
Sep 2023	-2.59M	0	1.11M
Dec 2023	-2.17M	2.27K	1.67M
Mar 2024	-2.14M	-23.79K	468.90K

ENDRA Life Sciences alternative data

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Employee count
Aug 2023	21
Sep 2023	21
Oct 2023	21
Nov 2023	21
Dec 2023	21
Jan 2024	21
Feb 2024	21
Mar 2024	21
Apr 2024	21
May 2024	21
Jun 2024	21
Jul 2024	21

ENDRA Life Sciences
Hedge Funds Holdings Q1 2023

2.80% -5.23%

of NDRA is owned by hedge funds

8 -5

hedge funds hold NDRA stock

60.23K -112.62K

shares is hold by hedge funds

NDRA hedge funds holdings changes

ENDRA Life Sciences
Insider Trading

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Insider trades (number of shares)
Period	Buy	Sel
Aug 2022	40000	0
Nov 2022	10000	0
Dec 2022	1500	0
May 2023	140000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	18 May 2023	THORNTON MICHAEL MILOS officer: Chief Te..	Common Stock	15,000	$1.65	$24,750
Purchase	2 May 2023	DIGIANDOMENICO ANTHONY director director	Common Stock	83,333	$1.2	$100,000
Purchase	2 May 2023	DIGIANDOMENICO ANTHONY director director	Warrants	41,667	$1.4	$58,334
Purchase	9 Dec 2022	THORNTON MICHAEL MILOS officer: Chief Te..	Common Stock	1,500	$3.4	$5,100
Purchase	23 Nov 2022	TOKMAN ALEXANDER Y director director	Common Stock	10,000	$0.17	$1,700
Purchase	22 Aug 2022	THORNTON MICHAEL MILOS officer: Chief Te..	Common Stock	20,000	$0.27	$5,400
Purchase	22 Aug 2022	TOKMAN ALEXANDER Y director director	Common Stock	20,000	$0.26	$5,200
Purchase	26 May 2022	THORNTON MICHAEL MILOS officer: Chief Te..	Common Stock	25,000	$0.21	$5,250
Purchase	18 May 2022	THORNTON MICHAEL MILOS officer: Chief Te..	Common Stock	25,000	$0.22	$5,500
Purchase	17 May 2022	MICHELON FRANCOIS ROGER director, officer..	Common Stock	5,100	$0.19	$969

NDRA insider trading transactions

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Methods and systems for exchange of equipment performance data Filling date: 24 Feb 2022 Issue date: 2 Aug 2022	24 Feb 2022	2 Aug 2022
Grant	Grant Utility: Methods and systems for exchange of equipment performance data Filling date: 25 Mar 2022 Issue date: 19 Jul 2022	25 Mar 2022	19 Jul 2022
Grant	Grant Utility: Methods and systems for exchange of equipment performance data Filling date: 25 Mar 2022 Issue date: 5 Jul 2022	25 Mar 2022	5 Jul 2022
Grant	Grant Utility: Broadband applicator for thermoacoustic signal generation Filling date: 17 Dec 2021 Issue date: 28 Jun 2022	17 Dec 2021	28 Jun 2022
Grant	Grant Utility: Acoustically compatible radio-frequency applicator method and system Filling date: 12 Feb 2020 Issue date: 24 May 2022	12 Feb 2020	24 May 2022
Grant	Grant Utility: Methods and systems for exchange of equipment performance data Filling date: 18 Oct 2021 Issue date: 26 Apr 2022	18 Oct 2021	26 Apr 2022
Grant	Grant Utility: Method and system for enhancing RF energy delivery during thermoacoustic imaging Filling date: 7 Nov 2018 Issue date: 19 Apr 2022	7 Nov 2018	19 Apr 2022
Grant	Grant Utility: Method and system for determining a material type of an object of interest Filling date: 1 Oct 2019 Issue date: 8 Mar 2022	1 Oct 2019	8 Mar 2022
Application	Application TISSUE-MIMICKING MATERIAL FOR A MULTI-MODALITY IMAGING PHANTOM Filling date: 21 May 2021 Issue date: 2 Dec 2021	21 May 2021	2 Dec 2021
Grant	Grant Utility: Tissue-mimicking material for a multi-modality imaging phantom Filling date: 21 May 2021 Issue date: 16 Nov 2021	21 May 2021	16 Nov 2021

ENDRA Life Sciences
Earnings Call Transcripts

Quarter	Transcript
Q1 2024 14 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 28 Mar 2024	Q4 2023 Earnings Call Transcript
Q3 2023 14 Nov 2023	Q3 2023 Earnings Call Transcript
Q2 2023 14 Aug 2023	Q2 2023 Earnings Call Transcript

NDRA earnings call transcripts

ENDRA Life Sciences
Executives

Insider	Age	Since	Compensation
Mr. Francois Michelon (1966) Chairman, Pres & Chief Executive Officer	59		$511,340
Mr. Michael Thornton (1968) Chief Technology Officer	57		$363,770

ENDRA Life Sciences
Latest News

Friday, 22 November 2024
08:00	ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement	businesswire.com
Friday, 15 November 2024
09:24	ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update	businesswire.com
Wednesday, 6 November 2024
08:00	ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent	businesswire.com
Friday, 30 August 2024
08:54	Data I/O And 2 Other Stocks Under $5 Executives Are Buying	benzinga.com
Thursday, 22 August 2024
17:54	ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript	seekingalpha.com
Wednesday, 7 August 2024
08:00	ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14	businesswire.com
Monday, 17 June 2024
08:11	Why Is ENDRA Life Sciences (NDRA) Stock Up 36% Today?	investorplace.com
Tuesday, 4 June 2024
09:21	ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering	businesswire.com
09:06	AM Best to Host Webinar on Engaging Defense Counsel Pre-Lawsuit	businesswire.com
Monday, 20 May 2024
08:00	ENDRA Provides Update Following In-person Meeting with FDA	businesswire.com
Tuesday, 14 May 2024
20:30	ENDRA Life Sciences Inc. (NDRA) Q1 2024 Earnings Call Transcript	Seeking Alpha
Thursday, 28 March 2024
21:10	ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript	Seeking Alpha
Tuesday, 14 November 2023
22:14	ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript	Seeking Alpha
Tuesday, 7 November 2023
16:05	ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023	Business Wire
Monday, 14 August 2023
21:44	ENDRA Life Sciences Inc. (NDRA) Q2 2023 Earnings Call Transcript	Seeking Alpha
Monday, 15 May 2023
21:48	ENDRA Life Sciences Inc. (NDRA) Q1 2023 Earnings Call Transcript	Seeking Alpha
Friday, 28 April 2023
09:09	Why Is ENDRA Life Sciences (NDRA) Stock Down 16% Today?	InvestorPlace
Tuesday, 14 March 2023
19:31	ENDRA Life Sciences Inc. (NDRA) Q4 2022 Earnings Call Transcript	Seeking Alpha
Tuesday, 7 March 2023
16:05	ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023	Business Wire
Monday, 14 November 2022
18:31	ENDRA Life Sciences Inc. (NDRA) Q3 2022 Earnings Call Transcript	Seeking Alpha
Monday, 15 August 2022
19:56	ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q2 2022 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 17 May 2022
19:09	Which Penny Stocks Are Investors Buying Right Now? 3 to Watch	PennyStocks
Thursday, 12 May 2022
22:37	ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Friday, 8 April 2022
09:31	Trading Penny Stocks on April 8th? What to Know on Friday	PennyStocks
Wednesday, 30 March 2022
19:07	ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q4 2021 Earnings Call Transcript	Seeking Alpha
Wednesday, 9 March 2022
08:00	ENDRA Life Sciences to Participate in Two March Investor Conferences	Business Wire
Wednesday, 5 January 2022
07:00	ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference	Business Wire
Thursday, 30 December 2021
09:12	Forget Bargains, Play 5 Stocks With Rising P/E Instead	Zacks Investment Research
Monday, 15 November 2021
21:35	ENDRA Life Sciences' (NDRA) CEO Francois Michelon on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
20:01	ENDRA Life Sciences Inc. (NDRA) Reports Q3 Loss, Misses Revenue Estimates	Zacks Investment Research

Frequently Asked Questions (FAQ)

What's the price of ENDRA Life Sciences stock today?

One share of ENDRA Life Sciences stock can currently be purchased for approximately $4.55.
When is ENDRA Life Sciences's next earnings date?

Unfortunately, ENDRA Life Sciences's (NDRA) next earnings date is currently unknown.
Does ENDRA Life Sciences pay dividends?

No, ENDRA Life Sciences does not pay dividends.
How much money does ENDRA Life Sciences make?

ENDRA Life Sciences has a market capitalization of 2.87M.
What is ENDRA Life Sciences's stock symbol?

ENDRA Life Sciences Inc. is traded on the NASDAQ under the ticker symbol "NDRA".
What is ENDRA Life Sciences's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of ENDRA Life Sciences?

Shares of ENDRA Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are ENDRA Life Sciences's key executives?
ENDRA Life Sciences's management team includes the following people:
- Mr. Francois Michelon Chairman, Pres & Chief Executive Officer(age: 59, pay: $511,340)
- Mr. Michael Thornton Chief Technology Officer(age: 57, pay: $363,770)
How many employees does ENDRA Life Sciences have?

As Jul 2024, ENDRA Life Sciences employs 21 workers.
When ENDRA Life Sciences went public?

ENDRA Life Sciences Inc. is publicly traded company for more then 8 years since IPO on 30 Jun 2017.
What is ENDRA Life Sciences's official website?

The official website for ENDRA Life Sciences is endrainc.com.
Where are ENDRA Life Sciences's headquarters?

ENDRA Life Sciences is headquartered at 3600 Green Court, Ann Arbor, MI.
How can i contact ENDRA Life Sciences?

ENDRA Life Sciences's mailing address is 3600 Green Court, Ann Arbor, MI and company can be reached via phone at +7 343350468.

ENDRA Life Sciences Inc.

endrainc.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

+7 343350468

3600 Green Court
Ann Arbor, MI 48105-1570

CIK: 0001681682
ISIN: US29273B3024
CUSIP: 29273B104